Aspirin and Conray drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Aspirin (aspirin) and Conray (iothalamate meglumine). Common drug interactions include anxiety among females and emotional distress among males.
The phase IV clinical study analyzes what interactions people have when they take Aspirin and Conray. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.
What is Aspirin?
Aspirin has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 632,088 Aspirin users. Check the latest studies of Aspirin.
What is Conray?
Conray has active ingredients of iothalamate meglumine. eHealthMe is studying from 317 Conray users. Check the latest studies of Conray.
16 people who take Aspirin and Conray together, and have interactions are studied.

What are the common drug interactions of Aspirin and Conray, by gender? *:
female:
- Anxiety
- Back pain
- Bone density decreased
- Bone loss
- Depression
- Mobility decreased (ability to move is reduced)
- Multiple fractures
- Osteonecrosis (death of bone)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Osteoporosis (bones weak and more likely to break)
male:
- Emotional distress
- Pain
- Chronic kidney disease
- Foot fracture
- Fracture
- Hip fracture
- Limb injury
- Nephrogenic fibrosing dermopathy (involves fibrosis of skin, joints, eyes due to kidney disease)
- Renal failure (kidney dysfunction)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
What are the common drug interactions of Aspirin and Conray, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Anxiety
- Back pain
- Bone density decreased
- Bone loss
- Depression
- Mobility decreased (ability to move is reduced)
- Multiple fractures
- Osteonecrosis (death of bone)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Osteoporosis (bones weak and more likely to break)
40-49:
n/a
50-59:
- Osteonecrosis (death of bone)
- Bone loss
- Emotional distress
- Osteoporosis (bones weak and more likely to break)
- Pain
- Decreased activity
- Depression
- Dysstasia (difficulty in standing)
- Rash
60+:
- Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
- Emotional distress
- Osteopenia (a condition where bone mineral density is lower than normal)
- Osteoporosis (bones weak and more likely to break)
- Tooth loss
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Areflexia (absence of a reflex)
- Bradycardia (abnormally slow heart action)
- Cardiac arrest
What are the existing conditions these people have? *
- Hiv Infection: 8 people, 50.00%
- Pain: 4 people, 25.00%
- Skeletal Injury (bone and supporting muscle injury): 2 people, 12.50%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 12.50%
- Infection: 2 people, 12.50%
- High Blood Pressure: 2 people, 12.50%
- Diabetes: 2 people, 12.50%
- Cyst (a closed sac): 2 people, 12.50%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 12.50%
* Approximation only. Some reports may have incomplete information.
Do you take Aspirin and Conray?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Aspirin and Conray:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Aspirin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Conray:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aspirin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Conray and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
- Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
How the study uses the data?
The study uses data from the FDA. It is based on aspirin and iothalamate meglumine (the active ingredients of Aspirin and Conray, respectively), and Aspirin and Conray (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Oxycodone and Striverdi Respimat - 6 seconds ago
- General Physical Condition Abnormal and Abdominal Pain - 8 seconds ago
- Osteopenia and Flatulence - 21 seconds ago
- High Blood Cholesterol and Joint Effusion - 38 seconds ago
- Drug interactions of Valacyclovir and Droperidol - 43 seconds ago
- Drug interactions of Metformin and Volmax - 44 seconds ago
- Could Diclofenac cause Irritable Bowel Syndrome? - 46 seconds ago
- Could Acetaminophen cause Energy Increased? - 51 seconds ago
- Drug interactions of Ranexa and Crestor - 51 seconds ago
- Sinus Tachycardia and Drug Ineffective - 57 seconds ago